Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 5, 2008, Pages 475-481

  Perneczky, Robert ^a,d   Drzezga, Alexander ^a   Boecker, Henning ^a,b   Ceballos Baumann, Andres O ^a   Granert, Oliver ^c   Förstl, Hans ^a   Kurz, Alexander ^a   Häussermann, Peter ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Cognitive reserve; Dementia with Lewy bodies; Parkinson's disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; COGNITION; DAILY LIFE ACTIVITY; DEMENTIA WITH LEWY BODY; DIFFUSE LEWY BODY DISEASE; EDUCATION; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ACTIVITIES OF DAILY LIVING; AGED; ANTIPARKINSON AGENTS; BRAIN CHEMISTRY; COGNITION; DATA INTERPRETATION, STATISTICAL; DEMENTIA; EDUCATION; FEMALE; FUNCTIONAL LATERALITY; GLUCOSE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEVODOPA; LEWY BODY DISEASE; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY;

EID: 55149096543     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167791     Document Type: Article

References (35)

1. Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H: The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord 1998;9(suppl 2):20-26.
2. Reisberg B, Finkel S, Overall J, Schmidt-Gollas N, Kanowski S, Lehfeld H, Hulla F, Sclan SG, Wilms HU, Heininger K, Hindmarch I, Stemmler M, Poon L, Kluger A, Cooler C, Bergener M, Hugonot-Diener L, Robert PH, Antipolis S, Erzigkeit H: The Alzheimer's disease activities of daily living international scale (ADL-IS). Int Psychogeriatr 2001;13:163-181.
3. Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S: An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;11(suppl 2):S33-S39.
4. Jagust W, Reed B, Mungas D, Ellis W, Decarli C: What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology 2007;69:871-877.
5. 18F-FDG-PET-study. Neurobiol Aging 2007;28:42-50.
6. Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE: Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001;50:358-365.
7. Yong SW, Yoon JK, An YS, Lee PH: A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol 2007;14:1357-1362.
8. Perneczky R, Hartmann J, Grimmer T, Drzezga A, Kurz A: Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment. J Geriatr Psychiatry Neurol 2007;20:84-88.
9. Salmon E, Lespagnard S, Marique P, Peeters F, Herholz K, Perani D, Holthoff V, Kalbe E, Anchisi D, Adam S, Collette F, Garraux G: Cerebral metabolic correlates of four dementia scales in Alzheimer's disease. J Neurol 2005;252:283-290.
10. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A: Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-144.
11. Stern Y: What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460.
12. Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL: Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003;60:1909-1915.
13. Perneczky R, Drzezga A, Diehl-Schmid J, Schmid G, Wohlschlager A, Kars S, Grimmer T, Wagenpfeil S, Monsch A, Kurz A: Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxyglucose-positron emission tomography. J Neurol Neurosurg Psychiatry 2006;77:1060-1063.
14. Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, Marder KS, Bell KL, Sackeim HA, Van Heertum RL, Moeller JR, Stern Y: Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 2003;60:359-365.
15. Perneczky R, Haussermann P, Diehl-Schmid J, Boecker H, Forstl H, Drzezga A, Kurz A: Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study. Dement Geriatr Cogn Disord 2007;23:316-322.
16. Perneczky R, Diehl-Schmid J, Drzezga A, Kurz A: Brain reserve capacity in frontotemporal dementia: a voxel-based 18F-FDG PET study. Eur J Nucl Med Mol Imaging 2007;34:1082-1087.
17. Perneczky R, Diehl-Schmid J, Pohl C, Drzezga A, Kurz A: Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve. Brain Res 2007;1133:178-185.
18. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
19. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
20. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-652.
21. Thalmann B, Monsch AU: CERAD. The Consortium to Establish a Registry for Alzheimer's Disease. Neuropsychologische Testbatterie. Basel, Memory Clinic Basel, 1997.
22. Folstein MF, Folstein SE, McHugh PR: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
23. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
24. Fahn S, Elton R, members of the UPDRS Development Committee: Unified Parkinson's Rating Scale; in Fahn S, Marsden C, Calne D, Goldstein M (eds): Recent Developments in Parkinson's Disease. Florhan Park, MacMillan Healthcare Information, 1987.
25. Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, Shing M, Kolbe H, van Den Hoff J, Fricke H, Dengler R, Samii M, Knapp WH: Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord 2001;16:1014-1022.
26. Frackowiak RS, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC: Characterising brain images with the general linear model;in Frackowiak RS, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC (eds): Human Brain Function. San Diego, Academic Press, 1997, pp 74-75.
27. Friston KJ, Frith CD, Liddle PF, Frackowiak RS: Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690-699.
28. Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, Weilke F, Ring J, Schwaiger M, Bartenstein P: Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain 2001;92:295-305.
29. Foldi NS, Lobosco JJ, Schaefer LA: The effect of attentional dysfunction in Alzheimer's disease: theoretical and practical implications. Semin Speech Lang 2002;23:139-150.
30. Knight RG: Controlled and automatic memory process in Alzheimer's disease. Cortex 1998;34:427-435.
31. Jefferson AL, Barakat LP, Giovannetti T, Paul RH, Glosser G: Object perception impairments predict instrumental activities of daily living dependence in Alzheimer's disease. J Clin Exp Neuropsychol 2006;28:884-897.
32. Goodale MA, Milner AD: Separate visual pathways for perception and action. Trends Neurosci 1992;15:20-25.
33. Boecker H, Ceballos-Baumann AO, Volk D, Conrad B, Forstl H, Haussermann P: Metabolic alterations in patients with Parkinson disease and visual hallucinations. Arch Neurol 2007;64:984-988.
34. Geser F, Wenning GK, Poewe W, McKeith I: How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 2005;20(suppl 12):S11-S20.
35. Iseki E: Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease. Neuropathology 2004;24:72-78.